Circulating very-long-chain saturated fatty acids and incident coronary heart disease in US men and women

Circulation

Volumn 132, Issue 4, 2015, Pages 260-268

  Malik, Vasanti S ^a   Chiuve, Stephanie E ^a,c   Campos, Hannia ^a   Rimm, Eric B ^a,c   Mozaffarian, Dariush ^a,b,c   Hu, Frank B ^a,c   Sun, Qi ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b TUFTS UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

coronary disease; fatty acids

Indexed keywords

ADIPONECTIN; C PEPTIDE; C REACTIVE PROTEIN; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; SATURATED FATTY ACID; TRANS FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID; VERY LONG CHAIN SATURATED FATTY ACID; BIOLOGICAL MARKER; FATTY ACID; LIPID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY RISK; DIET RESTRICTION; DISEASE ASSOCIATION; ENDOCRINE FUNCTION TEST; ERYTHROCYTE; FAT INTAKE; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; GENE LINKAGE DISEQUILIBRIUM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TELEPHONE INTERVIEW; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; AGED; BLOOD; CORONARY DISEASE; INCIDENCE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADULT; AGED; BIOMARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; CORONARY DISEASE; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84938566932     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.014911     Document Type: Article

References (32)

1. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS, Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008 134 933 944. doi: 10.1016/j.cell.2008.07.048
2. Lefebvre P, Chinetti G, Fruchart JC, Staels B, Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 2006 116 571 580. doi: 10.1172/JCI27989
3. Li Q, Tan L, Wang C, Li N, Li Y, Xu G, Li J, Polyunsaturated eicosapentaenoic acid changes lipid composition in lipid rafts. Eur J Nutr 2006 45 144 151. doi: 10.1007/s00394-005-0574-7
4. Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kröger J, Schulze MB, Crowe FL, Huerta JM, Guevara M, Beulens JW, van Woudenbergh GJ, Wang L, Summerhill K, Griffin JL, Feskens EJ, Amiano P, Boeing H, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Gonzalez C, Jakobsen MU, Kaaks R, Key TJ, Khaw KT, Kühn T, Mattiello A, Nilsson PM, Overvad K, Pala V, Palli D, Quirós JR, Rolandsson O, Roswall N, Sacerdote C, Sánchez MJ, Slimani N, Spijkerman AM, Tjonneland A, Tormo MJ, Tumino R, van Der A DL, van Der Schouw YT, Langenberg C, Riboli E, Wareham NJ, Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol 2014 2 810 818. doi: 10.1016/S2213-8587(14)70146-9
5. Alhazmi A, Stojanovski E, Garg ML, McEvoy M, Fasting whole blood fatty acid profile and risk of type 2 diabetes in adults: a nested case control study. PLoS One 2014 9 e97001. doi: 10.1371/journal.pone.0097001
6. Fretts AM, Mozaffarian D, Siscovick DS, Djousse L, Heckbert SR, King IB, McKnight B, Sitlani C, Sacks FM, Song X, Sotoodehnia N, Spiegelman D, Wallace ER, Lemaitre RN, Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study. J Am Heart Assoc 2014 3 e000889. doi: 10.1161/JAHA.114.000889
7. US Department of Agriculture, Agricultural Research Service USDA national nutrient database for standard reference, release 2014. http://www.Ars.Usda.Gov/nutrientdata. Accessed November 30, 2014
8. Jakobsson A, Westerberg R, Jacobsson A, Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 2006 45 237 249. doi: 10.1016/j.plipres.2006.01.004
9. Kihara A, Very long-chain fatty acids: elongation, physiology and related disorders. J Biochem 2012 152 387 395. doi: 10.1093/jb/mvs105
10. Yamazaki Y, Kondo K, Maeba R, Nishimukai M, Nezu T, Hara H, Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome. J Oleo Sci 2014 63 527 537
11. Rose G, Blackburn H, Cardiovascular Survey Method 1982 Geneva, Switzerland World Health Organization; Monograph series No. 56
12. Baylin A, Kabagambe EK, Siles X, Campos H, Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr 2002 76 750 757
13. Wolf AM, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Corsano KA, Rosner B, Kriska A, Willett WC, Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 1994 23 991 999
14. McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB, Spiegelman D, Hunter DJ, Colditz GA, Willett WC, Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 2002 76 1261 1271
15. Centers for Disease Control and Prevention About the National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes/about-nhanes.htm 2014. Accessed November 30, 2014
16. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM, Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003 113 159 170
17. Reilly D, Hao K, Jensen MK, Girman CJ, Rimm EB, Use of systems biology approaches to analysis of genome-wide association studies of myocardial infarction and blood cholesterol in the Nurses' Health Study and Health Professionals' Follow-Up Study. PLoS One 2013 8 e85369. doi: 10.1371/journal.pone.0085369
18. Gallo S, Egeland G, Meltzer S, Legault L, Kubow S, Plasma fatty acids and desaturase activity are associated with circulating adiponectin in healthy adolescent girls. J Clin Endocrinol Metab 2010 95 2410 2417. doi: 10.1210/jc.2009-1975
19. Miyazaki T, Shimada K, Hiki M, Kume A, Kitamura Y, Oshida K, Yanagisawa N, Kiyanagi T, Matsumori R, Daida H, High hexacosanoic acid levels are associated with coronary artery disease. Atherosclerosis 2014 233 429 433. doi: 10.1016/j.atherosclerosis.2014.01.031
20. Fernández-Real JM, Broch M, Vendrell J, Ricart W, Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003 26 1362 1368
21. Kulacoglu DN, Kocer I, Kurtul N, Keles S, Baykal O, Alterations of fatty acid composition of erythrocyte membrane in type 2 diabetes patients with diabetic retinopathy. Jpn J Ophthalmol 2003 47 551 556
22. Matsumori R, Miyazaki T, Shimada K, Kume A, Kitamura Y, Oshida K, Yanagisawa N, Kiyanagi T, Hiki M, Fukao K, Hirose K, Ohsaka H, Mokuno H, Daida H, High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome. Diabetes Res Clin Pract 2013 99 12 18. doi: 10.1016/j.diabres.2012.10.025
23. Antoku Y, Tsukamoto K, Miyoshi Y, Nagino H, Anezaki M, Suwa K, Narabe Y, Correlations of elevated levels of hexacosanoate in erythrocyte membranes with risk factors for atherosclerosis. Atherosclerosis 2000 153 169 173
24. Kawamura N, Moser HW, Kishimoto Y, Very long chain fatty acid oxidation in rat liver. Biochem Biophys Res Commun 1981 99 1216 1225
25. Braverman NE, Moser AB, Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 2012 1822 1442 1452. doi: 10.1016/j.bbadis.2012.05.008
26. Moser AB, Kreiter N, Bezman L, Lu S, Raymond GV, Naidu S, Moser HW, Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol 1999 45 100 110
27. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T, Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. J Biol Chem 2000 275 22293 22299. doi: 10.1074/jbc.M000248200
28. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ, Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 1998 273 5678 5684
29. Sandhir R, Khan M, Chahal A, Singh I, Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy. J Lipid Res 1998 39 2161 2171
30. Watkins PA, Fatty acid activation. Prog Lipid Res 1997 36 55 83
31. Reilly SM, Lee CH, PPAR delta as a therapeutic target in metabolic disease. FEBS Lett 2008 582 26 31. doi: 10.1016/j.febslet.2007.11.040
32. Winterbourn CC, Batt RD, The uptake of plasma fatty acids into human red cells and its relationship to cell age. Biochim Biophys Acta 1970 202 9 20